Business Context and Reporting Period
This Form 8-K reports on the results of the 2022 Annual Meeting of Stockholders held by MEDICINOVA, INC. on June 14, 2022. The company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC under the symbol MNOV.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
The filing details the voting outcomes for three specific proposals submitted to security holders. No material changes to financial operations or corporate structure outside of these governance votes are reported.
Outlook, Risks, and Voting Results
The following matters were approved or elected at the Annual Meeting:
- Director Election: Carolyn Beaver was elected as a Class III Director to serve until the 2025 Annual Meeting.
- Independent Auditor: The selection of BDO USA, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022, was ratified.
- Executive Compensation: The advisory proposal to approve the compensation of named executive officers was approved.
Voting Statistics:
- Record Date (April 18, 2022): 49,043,246 shares issued and outstanding.
- Attendance: 30,788,491 shares present (constituting a quorum).
- Director Vote (Carolyn Beaver): 22,205,791 For; 4,572,163 Against; 841,719 Abstain.
- Auditor Ratification: 25,572,623 For; 2,536,781 Against; 2,678,087 Abstain.
- Compensation Approval: 19,215,380 For; 5,422,078 Against; 2,982,515 Abstain.
Investor Verification Checklist
- Verify the definitive proxy statement filed on April 26, 2022, for detailed background on the director nominee and executive compensation.
- Confirm the appointment of BDO USA, LLP as the auditor for the fiscal year ending December 31, 2022.
- Review the company's most recent 10-K or 10-Q filings for financial metrics, as this 8-K contains no financial data.